Allergen-specific immunotherapy (hyposensitization). Part 1. Basics and subcutaneous application;Die allergenspezifische immuntherapie (hyposensibilisierung): Teil 1. Grundlagen und subkutane applikation

HNO

Volumn 48, Issue 1, 2000, Pages 59-67

  Klimek, L ^a  

^a DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; PHENOL;

ANAPHYLAXIS; CLINICAL PRACTICE; DESENSITIZATION; IMMUNOTHERAPY; REVIEW; RISK ASSESSMENT; STANDARDIZATION; T LYMPHOCYTE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

ALLERGENS; DESENSITIZATION, IMMUNOLOGIC; HUMANS; INJECTIONS, SUBCUTANEOUS; RESPIRATORY HYPERSENSITIVITY; TH1 CELLS; TH2 CELLS; TREATMENT OUTCOME;

EID: 0034064499     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001060050012     Document Type: Review

References (65)

1. Balda BR, Baumgarten C, Klimek L, et al. (1998) Tree pollen allergy can be efficiently treated by shortterm immunotherapy (STI) with 7 preseasonal injections of molecular standardized unmodified allergens. Allergy 53:740-748
2. Bauer CP (1993) Untersuchung zur Asthmaprävention durch die spezifische Immuntherapie bei Kindern (Abstract). Allergologie 16:468
3. Baumgarten C, Kunkel G, Rudolph R (1982) Vergleichende Untersuchungen von Graspollen-Allergikern behandelt mit Graspollenallergoid sowie an Aluminium-hydroxid adsorbierten Graspollen-Allergenen. Allergologie 5:89-96
4. Bellinghausen I, Enk AH, Mohamadzadeh M, et al.(1996) Epidermal cells enhance inter leukin 4 and immunoglobulin E production after stimulation with protein allergen. J Invest Dermatol
5. Björksten B, Möller C, Broberger U, et al. (1986) Clinical and immunological effects of oral immunotherapy with a standardized birch pollen extract. Allergy 41:290-295
6. Bousquet J, Hejjaoui A, Skassa Brociek W, et al. (1988) Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. I. Rush immunotherapy with allergoids and standardized orchard grass-pollen extract. J Allergy Clin Immunol 82:439-446
7. Bousquet J, Maasch HJ, Martinot B, et al. (1988) Double blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy. J Allergy Clin Immunol 82:439-446
8. Büchner K, Siepe M (1995) Nutzen der Hyposensibilisierung unter wirtschaftlichen Aspekten. Allergo J 4:156-163
9. Chang TL, Shea CM, Urioste S, et al.(1990) Heterogenity of helper/inducer T lymphocytes. III. Responses of IL-2 and IL-4 producing clones to antigens presented by different accessory cells. J Immunol 145:2803
10. Creticos PS, Van Metre TE, Mardiney MR, et al. (1984) Dose response of IgE and IgG antibodies during ragweed immunotherapy. J Allergy Clin Immunol 73:94-104
11. DeKruyff RH, Fang Y, Umetsu DT (1992) IL-4 synthesis by in vivo primed keyhole limpet hemocyanin-specific CD4+ T cells. I. Influence of antigen concentration and antigen-presenting cell type. J Immunol 149:3468-3476
12. Durham SR, Varney VA, Gaga M, et al. (1991) Immunotherapy suppresses T lymphocyte infiltration in the cutaneous late phase reaction. J Allergy Clin Immunol 87:299
13. Ewan PW, Alexander MM, Snape C, et al. (1988) Effective hyposensitization in allergic rhinitis using a potent partially purified extract of house dust mite. Clin Allergy 18:501-508
14. Executive Committee American Academy of Allergy and Immunology (1986) Position statement. Personnel and equipment to treat systemic reactions caused by immunotherapy with allergenic extracts. J Allergy Clin Immunol 77:271
15. Executive Committee American Academy of Allergy and Immunology (1990) Position statement. The waiting period after allergen skin testing and immunotherapy. J Allergy Clin Immunol 85:526
16. Fischöder W, Neumann M, Veltmann G (1982) Ergebnisse der subkutanen und oralen spezifischen Hyposensibilisierung mit Inhalationsallergenen. Allergologie 5:24-33
17. Fuchs AM, Strauss MB (1959) The clinical evaluation and the preparation of standardization of suspensions of a new waterinsoluble whole ragweed pollen complex. J Allergy Clin Immunol 30:66
18. Geha RS, Communale M (1983) Regulation of immunoglobulin E antibody synthesis in man by antiidiotypic antibodies. J Clin Invest 71:46-54
19. Gleich GJ, Zimmermann EM, Henderson LL, et al. (1982) Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six-year prospective study. J Allergy Clin Immunol 70:261-271
20. Gronemeyer W (1967) Pollenallergie. In: Hansen K, Werner M (Hrsg) Lehrbuch der klinischen Allergie. Thieme, Stuttgart, S 167-178
21. Haugaard L, Dahl R (1992) Immunotherapy in patients allergic to cat and dog dander. I. Clinical results. Allergy 47:249-254
22. Haugaard L, Dahl R, Jacobsen L (1993) A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: clinical efficacy and side effects. J Allergy Clin Immunol 91:709-722
23. Hauser C, Snapper CM, Ohara J, et al. (1989) T helper cells grown with hapten-modified cultured Langerhans' cells produce interleukin 4 and stimulate IgE production by B cells. Eur J Immunol 19:245-251
24. Hedlin G, Graff-Lonnevig V, Heilborn H, et al. (1991) Immunotherapy with cat-and dog-dander extracts. V. Effects of 3 years treatment. J Allergy Clin Immunol 87:955-964
25. Hepner MJ, Ownby DR, Anderson JA, et al. (1990) Risk of systemic reactions in patients taking beta-blocker drugs receiving allergen immunotherapy injections. J Allergy Clin Immunol 86:407-411
26. Horak F (1982) Welche Faktoren begünstigen die Manifestation eines Asthma bronchiale bei Patienten mit Rhinitis allergica? Allergologie 5:243-245
27. Howarth PH, Holmberg K (1995) Allegic rhinitis: An increasing clinical problem. Allergy 50:4-5
28. Iliopoulos O, Proud D, Adkinson NF, Jr. (1991) Effects of immunotherapy on the early, late, and rechallenge reaction to provocation with allergen: changes in inflammatory mediators and cells. J Allergy Clin Immunol 87:855
29. Jacobsen L (1994) Preventive allergy treatment. Symposium of Specific Allergy. Final Program. Elsinore, Denmark, 41
30. Jacobsen L, Dreborg S, Moller C, et al. (1995) Preventive allergy treatment (PAT) by use of specific immunotherapy (SIT). Allergy 50:50-50
31. Jutel M, Pichler WJ, Skrbic D, et al. (1995) Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures. J Immunol 154:4187-4194
32. Kelso JM, Jones RT, Tellez R, et al. (1995) Oral allergy syndrome successfully treated with pollen immunotherapy. Ann Allergy Asthma Immunol 74:391-396
33. Kesarwala HH, Maccia C, Amaram N, et al. (1984) Suppressor T cells and soluble suppressor factors in allergy: effect of immunotherapy. Clin Allergy 14:519-524
34. Kjellmann N-IM (1994) Natural course of asthma and allergy in childhood. Pediatr Allergy Immunol 5:13-18
35. Klimek L, Reske-Kunz AB, Saloga J (1999) Spezifische Immuntherapie -Hyposensibilisierung. Thieme, Stuttgart
36. Klimek L, Wolf H, Mewes T, et al. (1999) The effect of short-term immunotherapy with molecular standardized grass and rye allergens on eosinophil cationic protein and tryptase in nasal secretions. J Allergy Clin Immunol 103:47-53
37. Lockey RF, Benedict LM, Turkeltaub PC (1987) Fatalities from immunotherapy and skin testing. J Allergy Clin Immunol 79:660
38. Lombardo M, Carreira J (1986) A comparison between pyridinic and non-pyridinic extraction of allergenic materials. Ann Allergy 56:72
39. Maasch HJ, Marsh DG (1987) Standardized extracts. Modified allergens - allergoids. Clin Rev Allergy 5:89-106
40. Malling HJ, Weeke B (1993) Position paper. Immunotherapy. Allergy 48:9-35 (and Appendicies)
41. Marsh DG (1971) Preparation and properties of "allergoids" derived from native pollen allergens by mild formalin treatment. Int Arch Allergy Appl Immunol 41:199-215
42. Marsh DG, Lichtenstein LM, Campbell DH (1970) Studies on "allergoids" prepared from naturally occurring allergens. 1. assay of allergenicity and antigenicity of formalinized rye group 1 component. Immunology 18:705-722
43. McMenamin C, Schon Hegrad M, et al. (1991) Regulation of IgE responses to inhaled antigens: cellular mechanisms underlying allergic sensitization versus tolerance induction. Int Arch Allergy Appl Immunol 94:78-82
44. Noon L (1911) Prophylactic inoculation of hay fever. Lancet 1:572-573
45. Norman PS (1988) Immunotherapy for nasal allergy (symposium). J Allergy Clin Immunol 81:992-996
46. Norman PS, Lichtenstein LM, Kagey-Sobotka A, et al. (1982) Controlled evaluation of allergoid in the immunotherapy of ragweed hay fever. J Allergy Clin Immunol 70:248-260
47. Norman PS, Marsh DG, Lichtenstein LM (1979) Long-term immunotherapy with ragweed allergen and allergoid. J Allergy Clin Immunol 63:167
48. Norman PS, Van Metre TE (1990) The safety of allergenic immunotherapy. J Allergy Clin Immunol 85:522
49. Ohman JL (1989) Allergen immunotherapy in asthma: evidence for efficacy. J Allergy Clin Immunol 84:133-140
50. Rak S, Löwenhagen O, Venge P (1988) The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients. J Allergy Clin Immunol 82:470-480
51. Rocklin RE (1983) Clinical and immunologic aspects of allergen-specific immunotherapy in patients with seasonal allergic rhinitis and/or allergic asthma. J Allergy Clin Immunol 72:323-334
52. Rocklin RE, Pence H, Kaplan H, et al. (1974) Cell-mediated immune response of ragweed-sensitive patients to ragweed antigen E: in vitro lymphocyte transformation and elaboration of lymphocyte mediators. J Clin Invest 53:735-744
53. Rocklin RE, Sheffer AL, Greineder DK, et al. (1980) Generation of antigen-specific suppressor cells during allergy desensitization.N Engl J Med 302:1213-1219
54. Sadan N, Rhyne MB, Mellits ED, et al. (1969) Immunotherapy of pollinosis in children. Investigation of the immunologic basis of clinical improvement. N Engl J Med 280:623
55. Saloga J, Renz H, Lack G, et al. (1993) Development and transfer of immediate cutaneous hypersensitivity in mice exposed to aerosolized antigen. J Clin Invest 91:133-140
56. Secrist H, Chelen CJ, Wen Y, et al. (1993) Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 178:2123-2130
57. Secrist H, DeKruyff RH, Umetsu DT (1995) Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J Exp Med 181:1081-1089
58. Subcommittee on Insect Venom Allergy (1993) Position paper. Immunotherapy with hymenoptera venoms. Allergy 48:37-46
59. Taudorf E, Weeke B (1983) Orally administered grass pollen. Allergy 38:561-564
60. Toccaceli F, Rotigliano G, Bruno G, et al. (1981) Occurence of asthma in patients with allergic rhinitis. Prognostic value of clinical and laboratory tests (Abstract). Respiration 42:77
61. Tomasi TB (1980) Oral tolerance. Transplantation 29:3536
62. Urbanek R, Kuhn W, Binder U (1983) Untersuchungen zur Wirksamkeit oraler und parenteraler Hyposensibilisierung mit Pollen-Extrakten. Dtsch Med Wochenschr 108:1433-1437
63. Van Metre TE, Adkinson NF, Kagey-Sobotka A, et al. (1990) Immunotherapy decreases skin sensitivity to ragweed extract: demonstration by midpoint skin test titration. J Allergy Clin Immunol 87:299
64. Varney VA, Hamid QA, Gaga M, et al. (1993) Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Gin Invest 92:644-651
65. Zenner HP, Baumgarten C, Rasp G, et al. (1997) Short-term immunotherapy:A prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis. J Allergy Clin Immunol 100:23-29